All In MedTech

Device Trial Radar · NCT00576147

A Multi-Center Study of Near-Infrared Spectroscopy (NIRS) for Hematoma Detection

Last checked: Nov 20, 2026Latest source record: Nov 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

431

Actual

Start

Jul 2006

Primary completion

Jan 2011

Study completion Jan 2011

Sponsor

Lead sponsor
InfraScan, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Dec 18, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purposes of this study are: 1. To determine the sensitivity and specificity of the Near-Infrared Spectroscopy (NIRS) measurements for identifying intracranial hematomas due to trauma. 2. To determine the reproducibility of the Near-Infrared Spectroscopy (NIRS) measurements with different operators and at different centers

Conditions

  • TBI (Traumatic Brain Injury)

Interventions

  • InfrascannerDevice

    The main Near-Infrared spectroscopy (NIRS) head measurement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 1) Sensitivity of the Near-Infrared Spectroscopy (NIRS) Measurements for Identifying Intracranial Hematomas Due to Trauma. 2) Specificity of the Near-Infrared Spectroscopy (NIRS) Measurements for Identifying Intracranial Hematomas Due to Trauma.Time frame: 2 years

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Johns Hopkins University

    Baltimore, Maryland

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.